Editorial Board About Us

Nephrolithiasis

All articles from this key word are listed below.

Volume 1, Number 4 Meeting Reviews

Stones, BPH, Renal and Prostate Disease Discussed at Jackson Hole

19th Annual Jackson Hole Urologic Conference

Michael K Brawer

Infertility Nephrolithiasis Cancer, prostate Ureteropelvic junction obstruction Benign prostatic hyperplasia (BPH)Incontinence,urinary

Volume 2, Number 2 Meeting Reviews

Strategies for the Management of Exstrophy, Nonpalpable Testis, Hydronephrosis

Annual Meeting, American Academy of Pediatrics Section on Urology

Vesicoureteral reflux Bladder exstrophy Nephrolithiasis Hydronephrosis Undescended testis

Volume 5, Number 4 Review Articles

Drug-Induced Urinary Calculi

Therapeutic Challenges

Ojas D Shah Brian R Matlaga Dean G Assimos

Nephrolithiasis Urinary calculi Carbonic anhydrase inhibitors Sulfa medications Ephedrine Indinavir

Volume 5, Number 3 Meeting Reviews

Best of the 2003 AUA Annual Meeting

Highlights from the 2003 Annual Meeting of the American Urological Association, April 26-May 1, 2003

Randall B Meacham Bob Djavan Arie S Belldegrun Allan J Pantuck Mesut Remzi Michael Dobrovits Matthew B Gretzer Kazumasa Torimoto Dean G Assimos Ellen Shapiro Alan W Partin Michael B Chancellor J Curtis Nickel Jacob Rajfer Claus G Roehrborn Michael K Brawer

Prostate cancer Renal cell carcinoma Benign prostatic hyperplasia Depression Bladder cancer Lower urinary tract symptoms Urinary tract infection Prostate-specific antigen Nephrolithiasis Overactive bladder Radical prostatectomy Peyronie’s disease Gleason score Transrectal ultrasound Erectile dysfunction Chronic prostatitis/chronic pelvic pain syndrome Acute urinary retention International Prostate Symptom Score Bacille Calmette-Guérin therapy Chronic Prostatitis Symptom Index MTOPS trial PLESS study Prostate tumor markers SELDI-TOF

Volume 8, Number 2 Meeting Reviews

Endourology: A Basic Science and Clinical Update

Meeting Review

Highlights from the 23rd World Congress on Endourology and the Shockwave Lithotripsy 21st Basic Research Symposium August 23–26, 2005 Amsterdam, The Netherlands [Rev Urol. 2006;8(2):83-86]

Laparoscopy Oncology Nephrolithiasis Shock wave lithotripsy Endourology Ureteral physiology Ureteral stents

Volume 8, Number 1 Meeting Reviews

Updates in Pediatric Urology

Meeting Review

Highlights of the American Academy of Pediatrics Section on Urology Annual Meeting October 8-10, 2005 Washington, DC

Vesicoureteral reflux Nephrolithiasis Cryptorchidism Pediatrics Bladder reconstruction Deflux

Volume 10, Number 3 Review Articles

Hypercalcemic States Associated With Nephrolithiasis

Management Update

Corey Passman Brandon L Craven Dean G Assimos

Although kidney stone formation due to hypercalcemic states is rare, it is important for urologists to understand the pathophysiology of these conditions, methods of diagnosis, and treatments. This should foster a quicker diagnosis and institution of appropriate therapy. The latter typically leads to the attenuation of kidney stone activity. Moreover, these patients have a systemic disease, and therapy has other health benefits. [Rev Urol. 2008;10(3):218-226]

Nephrolithiasis Vitamin D Sarcoidosis Hypercalcemia Calcium homeostasis Calcitriol Parathyroid hormone Hyperparathyroidism

Volume 10, Number 3 Case Review

Shock Wave Lithotripsy and Renal Hemorrhage

Case Review

J Kellogg Parsons Jonathan Silberstein Charles M Lakin

Although shock wave lithotripsy is a safe and efficacious treatment for nephrolithiasis, the most common acute complication is renal hemorrhage. Shock wave–induced renal hemorrhage is a potentially devastating injury if not promptly recognized and treated appropriately. The authors report a large perirenal hematoma occurring after shock wave lithotripsy and review the causes, prevention, and treatment of shock wave–induced renal hemorrhage. [Rev Urol. 2008;10(3):236-241]

Nephrolithiasis Shock wave lithotripsy Hematoma

Volume 11, Number 2 Meeting Reviews

Best of the 2009 AUA Annual Meeting

Highlights From the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL

B Shuch Naoki Yoshimura Arie S Belldegrun F Pouliot Michael B Chancellor Ellen Shapiro Alan W Partin Dean G Assimos Stacy Loeb J Curtis Nickel Claus G Roehrborn Michael K Brawer

Prostate cancer screening Obesity Benign prostatic hyperplasia Lower urinary tract symptoms Vesicoureteral reflux Nephrolithiasis Stress urinary incontinence Inflammation Silodosin Hormonal therapy Tumor markers TMPRSS2ERG 4-Kallikrein panel Botulinum toxin type A Male voiding dysfunction Benign prostatic specific antigen Roux-en-Y gastric bypass surgery Genitourinary pain index UPOINT clinical phenotype system Nephron-sparing surgery Watchful waiting Laparoscopy for adrenal cortical carcinoma Partial adrenalectomy Urethral trauma Pediatric urethral stricture Enteric urologic surgery

Volume 12, Number 4 Review Articles

Metabolic Syndrome and Urologic Diseases

Mangement Review

Haluk Akpinar Ilya Gorbachinsky

Metabolic syndrome (MetS) is a complex entity consisting of multiple interrelated factors including insulin resistance, central adiposity, dyslipidemia, endothelial dysfunction and atherosclerotic disease, low-grade inflammation, and in males, low testosterone levels. MetS has been linked to a number of urologic diseases including nephrolithiasis, benign prostatic hyperplasia and lower urinary tract symptoms, erectile dysfunction, male infertility, female incontinence, and prostate cancer. This article reviews the relationships between MetS and these entities. Urologists need to be cognizant of the impact that MetS has on urologic diseases as well as on overall patient health.[Rev Urol. 2010;12(4):e157-e180 doi: 10.3909/riu0487]© 2010 MedReviews®, LLC

Obesity Metabolic syndrome Benign prostatic hyperplasia Nephrolithiasis Hypogonadism Cardiovascular disease Insulin resistance Endothelial dysfunction